296 related articles for article (PubMed ID: 30896886)
41. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
42. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
Mishra MN; Vangara KK; Palakurthi S
Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
Choi HS; Kim YK; Yun PY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
[TBL] [Abstract][Full Text] [Related]
46. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
Imai Y; Ishikawa E; Asada S; Sugimoto Y
Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
[TBL] [Abstract][Full Text] [Related]
47. Livin promotes the progression and metastasis of breast cancer through the regulation of epithelial‑mesenchymal transition via the p38/GSK3β pathway.
Han Y; Zhang L; Wang W; Li J; Song M
Oncol Rep; 2017 Dec; 38(6):3574-3582. PubMed ID: 29039608
[TBL] [Abstract][Full Text] [Related]
48. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.
Olofsson MH; Ueno T; Pan Y; Xu R; Cai F; van der Kuip H; Muerdter TE; Sonnenberg M; Aulitzky WE; Schwarz S; Andersson E; Shoshan MC; Havelka AM; Toi M; Linder S
Clin Cancer Res; 2007 Jun; 13(11):3198-206. PubMed ID: 17545523
[TBL] [Abstract][Full Text] [Related]
49. Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
Song JG; Lee YS; Park JA; Lee EH; Lim SJ; Yang SJ; Zhao M; Lee K; Han HK
Cancer Chemother Pharmacol; 2016 Oct; 78(4):735-44. PubMed ID: 27520631
[TBL] [Abstract][Full Text] [Related]
50. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.
Sun L; Burnett J; Gasparyan M; Xu F; Jiang H; Lin CC; Myers I; Korkaya H; Liu Y; Connarn J; He H; Zhang N; Wicha MS; Sun D
Oncotarget; 2016 Aug; 7(32):51408-51422. PubMed ID: 27285982
[TBL] [Abstract][Full Text] [Related]
51. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells.
Wu X; Zhang X; Sun L; Zhang H; Li L; Wang X; Li W; Su P; Hu J; Gao P; Zhou G
Cell Physiol Biochem; 2013; 32(2):344-54. PubMed ID: 23988382
[TBL] [Abstract][Full Text] [Related]
52. The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
Rigalli JP; Scholz PN; Tocchetti GN; Ruiz ML; Weiss J
Eur J Nutr; 2019 Feb; 58(1):139-150. PubMed ID: 29101532
[TBL] [Abstract][Full Text] [Related]
53. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
[TBL] [Abstract][Full Text] [Related]
55. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
[TBL] [Abstract][Full Text] [Related]
56. ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer.
Hasanabady MH; Kalalinia F
J Biosci; 2016 Jun; 41(2):313-24. PubMed ID: 27240991
[TBL] [Abstract][Full Text] [Related]
57. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
[TBL] [Abstract][Full Text] [Related]
58. β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.
Bar-Zeev M; Kelmansky D; Assaraf YG; Livney YD
Eur J Pharm Biopharm; 2018 Dec; 133():240-249. PubMed ID: 30367935
[TBL] [Abstract][Full Text] [Related]
59. A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.
Stewart TA; Azimi I; Thompson EW; Roberts-Thomson SJ; Monteith GR
Biochem Biophys Res Commun; 2015 Mar; 458(3):509-514. PubMed ID: 25666946
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells.
Li W; Liu C; Tang Y; Li H; Zhou F; Lv S
Asian Pac J Cancer Prev; 2011; 12(10):2575-80. PubMed ID: 22320957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]